Morgan Stanley Finance LLC Files 424B2 for New Securities Offering

TL;DR

**Morgan Stanley Finance LLC just dropped a new offering, check the pricing supplement!**

AI Summary

Morgan Stanley Finance LLC filed a 424B2 prospectus on March 24, 2026, detailing a new offering, likely structured notes or other securities, under their existing shelf registration (File No. 333-275587-01). This filing, specifically Pricing Supplement No. 14,973, indicates Morgan Stanley Finance LLC is actively raising capital or issuing new financial products. For investors, this means new investment opportunities or potential dilution if it's an equity-linked offering, and it reflects the company's ongoing financial activities and capital management strategies.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new financial products, which could impact the supply and demand dynamics for their existing securities and potentially offer new investment avenues for investors.

Risk Assessment

Risk Level: medium — The filing itself is a standard prospectus supplement, but the underlying securities being offered could carry varying levels of risk depending on their structure, which isn't fully detailed in this summary.

Analyst Insight

Investors should review the full 'PRICING SUPPLEMENT NO. 14,973' to understand the specific terms, risks, and potential returns of the securities being offered by Morgan Stanley Finance LLC before making any investment decisions.

Key Numbers

• 0001666268 — CIK for Morgan Stanley Finance LLC (Unique identifier for the filing entity)
• 0000895421 — CIK for Morgan Stanley (Unique identifier for the parent company)
• 333-275587-01 — File Number (Registration statement under which the offering is made)
• 2026-03-24 — Filing Date (Date the 424B2 was filed with the SEC)
• 14,973 — Pricing Supplement Number (Specific identifier for this particular offering document)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
• Morgan Stanley (company) — Parent company, also listed as a Filer
• March 24, 2026 (date) — Filing and acceptance date of the 424B2
• 1585 Broadway, New York, NY 10036 (location) — Mailing and business address for both filers
• 333-275587-01 (other) — File number for Morgan Stanley Finance LLC's registration statement
• 14,973 (other) — Pricing Supplement Number

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $2,760,000 — below) Aggregate principal amount: $2,760,000 Underliers: Dow Jones Industrial Av
• $969.10 — Estimated value on the pricing date: $969.10 per security. See "Estimated Value of t
• $7.50 — eds to us (3) Per security $1,000 $7.50 $992.50 Total $2,760,000 $20,70
• $992.50 — s (3) Per security $1,000 $7.50 $992.50 Total $2,760,000 $20,700 $2,739
• $20,700 — $7.50 $992.50 Total $2,760,000 $20,700 $2,739,300 (1) The securities will
• $2,739,300 — 992.50 Total $2,760,000 $20,700 $2,739,300 (1) The securities will be sold only
• $6.25 — may receive a structuring fee of up to $6.25 for each security from the agent or its
• $1,672.50 — or equal to its call threshold level: $1,672.50 If the final level of any underlier i
• $1,134.50 — #1 March 23, 2027 March 26, 2027 $1,134.50 #2 June 21, 2027 June 24, 2027
• $1,168.125 — #2 June 21, 2027 June 24, 2027 $1,168.125 #3 September 20, 2027 September 2
• $1,201.75 — ptember 20, 2027 September 23, 2027 $1,201.75 #4 December 20, 2027 December 23,
• $1,235.375 — December 20, 2027 December 23, 2027 $1,235.375 #5 March 20, 2028 March 23, 2028
• $1,269.00 — #5 March 20, 2028 March 23, 2028 $1,269.00 #6 June 20, 2028 June 23, 2028
• $1,302.625 — #6 June 20, 2028 June 23, 2028 $1,302.625 #7 September 20, 2028 September 2

Filing Documents

• ms14973_424b2-10701.htm (424B2) — 307KB
• ex-filingfees.htm (EX-FILING FEES) — 8KB
• image1.gif (GRAPHIC) — 76KB
• image2.gif (GRAPHIC) — 78KB
• image3.gif (GRAPHIC) — 88KB
• 0001839882-26-016783.txt ( ) — 743KB
• ex-filingfees_htm.xml (XML) — 2KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities do not guarantee the return of any principal and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal and do not pay interest. If the securities have not been automatically redeemed prior to maturity and the final level of any underlier is less than its downside threshold level, the payout at maturity will be an amount in cash that is significantly less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the worst performing underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities. The appreciation potential of the securities is limited by the fixed early redemption payment or payment at maturity specified for each determination date. The appreciation potential of the securities is limited by the applicable fixed early redemption payment or payment at maturity, as applicable, payable only if the closing level of each underlier is greater than or equal to its call threshold level on the related determination date. In all cases, you will not participate in any appreciation of any underlier, which could be significant. The securities are subject to early redemption risk. The term of your investment in the securities may be shortened due to the automatic early redemption feature of the securities. If the securities ar

View Full Filing

View this 424B2 filing on SEC EDGAR